Picture of Foghorn Therapeutics logo

FHTX — Foghorn Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Foghorn Therapeutics Q3 EPS USD -0.25

Nov 05 (Reuters) - Foghorn Therapeutics Q3 collaboration revenue USD 8.153 million.

Q3 net income USD -15.849 million

Recent news on Foghorn Therapeutics

See all news